OMER, Israel, Nov. 28, 2016 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced financial results for the third quarter ended September 30, 2016. “This quarter, we have achieved a number of clinical and regulatory milestones in key target markets, further supporting our globally expanding footprint,” said Chris Rowland, CEO of Medigus. “In...